Robert A. Bradway
Robert A. Bradway | |
|---|---|
| Education | Bachelor of Science in biology, Amherst College; MBA, Harvard University |
| Occupation | Business executive |
| Known for | Chairman and CEO of Amgen |
Robert A. Bradway (born ) is an American executive currently holding the positions of chairman and CEO at Amgen.
Education
Bradway earned a Bachelor of Science degree in biology from Amherst College and subsequently obtained an MBA from Harvard University.
Career
His professional journey began in 1985 at Morgan Stanley, where he worked as a healthcare investment banker. He eventually advanced to managing director in London, responsible for banking and corporate finance activities across Europe.
Bradway joined Amgen in 2006 as vice president of operations strategy. He then progressed to executive vice president and chief financial officer from 2007 to 2010, followed by serving as president and chief operating officer between 2010 and 2012. He became a member of Amgen's board in 2011, ascended to CEO in 2012, and took on the role of chairman in 2013.
During his tenure, Amgen's yearly revenue expanded from $17.3 billion in 2012 to $26 billion by 2021, while research and development spending reached $4.2 billion in 2020. Significant acquisitions under his leadership include the purchase of Iceland-based DeCODE genetics in 2012, the acquisition of Onyx Pharmaceuticals in 2013, and securing a 20.5% ownership stake in Beijing-based BeiGene in 2020.
Boards and volunteer activities
Bradway holds a position on the board of directors at Boeing. He was the featured speaker for the 2016 graduation ceremony at the Keck Graduate Institute and also delivered the commencement address in 2017 at the UCLA Anderson School of Management, where he serves on both the board of trustees and the Leonard D. Schaeffer Center for Health Policy and Economics. Additionally, he leads the CEO Roundtable on Cancer and participates as a member of the American Heart Association CEO Roundtable.
Public statements
In 2015, Bradway was a keynote presenter at the World Medical Innovation Forum and later spoke at UCLA Anderson's commencement in 2017. During June 2020, he took part in Fortune magazine's Brainstorm Health virtual event. After the 2020 killing of George Floyd, Bradway denounced the incident as "senseless" and pledged to tackle racial disparities within Amgen, highlighting a commitment to gradual advancement driven by scientific principles.
On October 1, 2020, Bradway appeared before the House Oversight Committee, where Representative Katie Porter questioned his earnings. Between 2017 and 2019, Bradway along with four other senior Amgen executives collectively received $124.2 million in compensation.